Bortezomib for the Treatment of De Novo HLA Antibody-related Antibody Mediated Rejection.
Al Meshari K.
Clinical Transplants 2009, Chapter 34
Abstract
Bortezomib for the Treatment of De Novo HLA Antibody-related Antibody Mediated Rejection.
- Product Code: CT09_CH34
- Availability: In Stock
-
$5.00